We had the opportunity to interview Dr. Julie Eggington, a local leader and pioneer in genomics and precision medicine. If you have ever embraced the tech term ‘hype cycle’ this is an interesting read and has us thinking about Salt Lake City’s BioHive Community vibe in general – it’s all about attention over hype.

Since the Human Genome Project started in 1990, genomics has presented a massive opportunity to improve and personalize healthcare. Investment in genomics deals have provided over $6.5B in total, driving applications in gene sequencing, diagnostics, precision medicine, and more.

But much of that investment defaults to the usual U.S. metros – Silicon Valley, Boston, New York, etc. To which, Dr. Eggington says,

“Why is that? There is no reason why investors shouldn’t be looking to Utah for innovation and deep talent in genomics and diagnostics. We excel. We really need to change perceptions.”

For over 50 years, the University of Utah has been a leader in human genetics. Genealogical data has provided a perfect storm of people and resources that have since spurred discoveries of the genetic causes behind cystic fibrosis, breast cancer, colon cancer, and many more. It has spawned great companies like Salt Lake City’s Myriad Genetics, a worldwide leader in molecular diagnostics.

Article continues here: https://slcecondev.com/2021/01/27/attention-over-hype-salt-lake-citys-genetic-testing-industry/